Total Payments
$174,603
2024 Payments
$2,138
Companies
15
Transactions
241
Medicare Patients
1,739
Medicare Billing
$807,988
Payment Breakdown by Category
Other$128,708 (73.7%)
Consulting$22,282 (12.8%)
Travel$17,823 (10.2%)
Food & Beverage$5,670 (3.2%)
Education$121.60 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $114,992 | 51 | 65.9% |
| Consulting Fee | $22,282 | 12 | 12.8% |
| Travel and Lodging | $17,823 | 58 | 10.2% |
| Honoraria | $13,716 | 8 | 7.9% |
| Food and Beverage | $5,670 | 110 | 3.2% |
| Education | $121.60 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $63,342 | 70 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $54,036 | 90 | $0 (2020) |
| Mylan Specialty L.P. | $19,679 | 25 | $0 (2022) |
| Monaghan Medical Corporation | $18,930 | 12 | $0 (2024) |
| Fisher & Paykel Healthcare Inc | $6,329 | 10 | $0 (2023) |
| Mylan Inc. | $5,902 | 12 | $0 (2019) |
| Philips Electronics North America Corporation | $4,200 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,173 | 9 | $0 (2022) |
| Vapotherm Inc | $552.00 | 1 | $0 (2021) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,138 | 2 | Monaghan Medical Corporation ($2,073) |
| 2023 | $22.37 | 1 | Fisher & Paykel Healthcare Inc ($22.37) |
| 2022 | $4,708 | 8 | Mylan Specialty L.P. ($4,529) |
| 2021 | $1,504 | 10 | Vapotherm Inc ($552.00) |
| 2020 | $14,472 | 14 | GlaxoSmithKline, LLC. ($6,512) |
| 2019 | $78,809 | 86 | GlaxoSmithKline, LLC. ($45,092) |
| 2018 | $23,436 | 47 | Sunovion Pharmaceuticals Inc. ($16,742) |
| 2017 | $49,513 | 73 | Sunovion Pharmaceuticals Inc. ($31,531) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Monaghan Medical Corporation | AeroChamber (Device) | Honoraria | Cash or cash equivalent | $2,073.22 | General |
| Category: Chamber | ||||||
| 10/03/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $65.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2023 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: myAIRVO | ||||||
| 08/31/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Pulmonology | ||||||
| 06/23/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/23/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $80.36 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/13/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Pulmonology | ||||||
| 05/03/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Oncology | ||||||
| 03/14/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Pulmonology | ||||||
| 01/18/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Consulting Fee | Cash or cash equivalent | $1,064.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/13/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Consulting Fee | Cash or cash equivalent | $1,060.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/06/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $120.50 | General |
| Category: Cardiovascular | ||||||
| 10/05/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Pulmonology | ||||||
| 09/08/2021 | Mylan Specialty L.P. | YUPELRI (Drug) | Consulting Fee | Cash or cash equivalent | $397.50 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/25/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $121.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $114.48 | General |
| Category: Respiratory | ||||||
| 06/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA, INCRUSE ELLIPTA | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 05/19/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Pulmonology | ||||||
| 04/29/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Pulmonology | ||||||
| 04/01/2021 | Vapotherm Inc | VAPOTHERM (Device) | Consulting Fee | Cash or cash equivalent | $552.00 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,064.00 | General |
| Category: Respiratory and Allergy | ||||||
| 12/07/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/02/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,064.00 | General |
| Category: Respiratory and Allergy | ||||||
| 10/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 407 | 1,597 | $359,385 | $183,030 |
| 2022 | 9 | 352 | 1,506 | $335,287 | $170,062 |
| 2021 | 10 | 553 | 2,512 | $692,365 | $288,884 |
| 2020 | 8 | 427 | 1,085 | $437,335 | $166,011 |
Total Patients
1,739
Total Services
6,700
Medicare Billing
$807,988
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 102 | 658 | $85,650 | $60,000 | 70.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 50 | 269 | $73,975 | $44,146 | 59.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 61 | 112 | $83,067 | $27,597 | 33.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 374 | $35,565 | $22,540 | 63.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 50 | 94 | $60,903 | $22,236 | 36.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 37 | $9,250 | $4,928 | 53.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 28 | 53 | $10,975 | $1,582 | 14.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 63 | 412 | $119,895 | $69,491 | 58.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 77 | 541 | $70,884 | $42,684 | 60.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 42 | 72 | $57,881 | $20,092 | 34.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 341 | $33,020 | $18,740 | 56.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 32 | 54 | $36,962 | $13,932 | 37.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $3,500 | $2,143 | 61.2% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 20 | 39 | $7,750 | $1,338 | 17.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 12 | 13 | $3,469 | $1,108 | 31.9% |
| 31502 | Change of breathing tube in windpipe | Facility | 2022 | 18 | 20 | $1,925 | $533.77 | 27.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 134 | 750 | $322,886 | $132,524 | 41.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 117 | 943 | $169,226 | $77,478 | 45.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 128 | 551 | $66,411 | $31,004 | 46.7% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 51 | 83 | $68,008 | $24,569 | 36.1% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 34 | 57 | $39,335 | $15,457 | 39.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 23 | 34 | $9,036 | $3,019 | 33.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $4,122 | $1,880 | 45.6% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2021 | 21 | 30 | $6,702 | $1,285 | 19.2% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 13 | 27 | $4,800 | $1,003 | 20.9% |
About Dr. Brian Carlin, MD
Dr. Brian Carlin, MD is a Critical Care Medicine healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285695114.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Carlin, MD has received a total of $174,603 in payments from pharmaceutical and medical device companies, with $2,138 received in 2024. These payments were reported across 241 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($114,992).
As a Medicare-enrolled provider, Carlin has provided services to 1,739 Medicare beneficiaries, totaling 6,700 services with total Medicare billing of $807,988. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Pittsburgh, PA
- Active Since 03/30/2006
- Last Updated 12/05/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285695114
Products in Payments
- TRELEGY ELLIPTA (Drug) $33,789
- UTIBRON (Drug) $25,234
- Yupelri (Drug) $19,281
- ANORO (Drug) $17,656
- LONHALA MAGNAIR (Drug) $13,151
- Utibron (Drug) $6,492
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $6,307
- Wixela Inhub (Drug) $5,902
- SRC Und (Device) $4,200
- SEEBRI (Drug) $4,025
- BROVANA (Drug) $4,010
- AeroChamber (Device) $3,243
- AeroEclipse (Device) $1,705
- SYMBICORT (Drug) $778.00
- VAPOTHERM (Device) $552.00
- YUPELRI (Drug) $397.50
- DUPIXENT (Biological) $190.11
- Lonhala Magnair (Drug) $121.60
- NUCALA (Biological) $121.00
- ELIQUIS (Drug) $120.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Pittsburgh
Tariq Cheema, Md, MD
Critical Care Medicine — Payments: $450,610
Critical Care Medicine $450,610
Kees Polderman, Md, MD
Critical Care Medicine — Payments: $411,113
Critical Care Medicine $411,113
Khalid Malik, Md, MD
Critical Care Medicine — Payments: $144,539
Critical Care Medicine $144,539
Anil Singh, M.d, M.D
Critical Care Medicine — Payments: $79,897
Critical Care Medicine $79,897
Michael Apostolis, M.d, M.D
Critical Care Medicine — Payments: $59,035
Critical Care Medicine $59,035
Raghavan Murugan
Critical Care Medicine — Payments: $17,503
Critical Care Medicine $17,503